Literature DB >> 3484510

Tissue-specific phosphorylation of complement receptors CR1 and CR2.

P S Changelian, D T Fearon.   

Abstract

CR1 of neutrophils and monocytes may exist in a resting state, in which it only binds ligand-coated particles, or an activated state, in which it mediates phagocytosis. Because the activated state of CR1 can be induced by the stimulation of protein kinase C with PMA, CR1 was assessed for phosphorylation. Purified human neutrophils, monocytes, eosinophils, tonsilar lymphocytes, SB cells, and erythrocytes were labeled with 32PO4 and incubated with buffer or 100 ng/ml PMA. Membrane proteins were immunoprecipitated and analyzed by SDS-PAGE and autoradiography. CR1, unlike HLA class I heavy chain, was not constitutively phosphorylated by any cell type. PMA induced phosphorylation of CR1 in three phagocytic cell types, but did not induce the phosphorylation of CR3 or FcR. FMLP also induced the phosphorylation of CR1 in neutrophils. In contrast, PMA did not induce phosphorylation of CR1 in tonsilar B lymphocytes, SB cells, or erythrocytes, indicating restriction of this reaction to phagocytic cell types. This may be due to differences in the structure or presentation of the cytoplasmic domain of CR1 in phagocytic vs. nonphagocytic cells. Phosphorylation of CR2, however, did occur in PMA-treated B lymphocytes and SB cells, suggesting that this receptor, rather than CR1, may be involved in regulation of B lymphocyte function.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484510      PMCID: PMC2188014          DOI: 10.1084/jem.163.1.101

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  Monoclonal antibodies defining distinctive human T cell surface antigens.

Authors:  P Kung; G Goldstein; E L Reinherz; S F Schlossman
Journal:  Science       Date:  1979-10-19       Impact factor: 47.728

2.  A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni.

Authors:  M A Vadas; J R David; A Butterworth; N T Pisani; T A Siongok
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

3.  Characterization of a human B lymphocyte-specific antigen.

Authors:  P Stashenko; L M Nadler; R Hardy; S F Schlossman
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

4.  Regulation of contractile proteins by phosphorylation.

Authors:  R S Adelstein
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

5.  Two mRNAs can be produced from a single immunoglobulin mu gene by alternative RNA processing pathways.

Authors:  P Early; J Rogers; M Davis; K Calame; M Bond; R Wall; L Hood
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

6.  Disposition of T200 glycoprotein in the plasma membrane of a murine lymphoma cell line.

Authors:  M B Omary; I S Trowbridge
Journal:  J Biol Chem       Date:  1980-02-25       Impact factor: 5.157

7.  Phosphorylation in vivo and in vitro of human histocompatibility antigens (HLA-A and HLA-B) in the carboxy-terminal intracellular domain.

Authors:  J S Pober; B C Guild; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

8.  Isolation and properties of actin, myosin, and a new actinbinding protein in rabbit alveolar macrophages.

Authors:  J H Hartwig; T P Stossel
Journal:  J Biol Chem       Date:  1975-07-25       Impact factor: 5.157

9.  Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.

Authors:  D T Fearon
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

Review 10.  Augmentation of macrophage complement receptor function in vitro. I. Characterization of the cellular interactions required for the generation of a T-lymphocyte product that enhances macrophage complement receptor function.

Authors:  J A Griffin; F M Griffin
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

View more
  27 in total

1.  The human fibroblast receptor for gp86 of human cytomegalovirus is a phosphorylated glycoprotein.

Authors:  S Keay; B Baldwin
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes.

Authors:  E Sariban; K Imamura; R Luebbers; D Kufe
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 3.  Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.

Authors:  L Hutt-Fletcher
Journal:  Springer Semin Immunopathol       Date:  1991

4.  Internalization pathway of C3b receptors in human neutrophils and its transmodulation by chemoattractant receptors stimulation.

Authors:  J L Carpentier; D P Lew; J P Paccaud; R Gil; B Iacopetta; M Kazatchkine; O Stendahl; T Pozzan
Journal:  Cell Regul       Date:  1991-01

5.  Decreased expression of complement receptor type 2 (CR2) on neoplastic B cells of chronic lymphocytic leukaemia.

Authors:  J A Tooze; D H Bevan
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

6.  Complement-mediated phagocytosis of herpes simplex virus by granulocytes. Binding or ingestion.

Authors:  J A Van Strijp; K P Van Kessel; M E van der Tol; J Verhoef
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

7.  Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies.

Authors:  M Barel; A Fiandino; F Lyamani; R Frade
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Identification of murine complement receptor type 2.

Authors:  J D Fingeroth; M A Benedict; D N Levy; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

9.  Up-regulation of the iC3b receptor (CR3) is neither necessary nor sufficient to promote neutrophil aggregation.

Authors:  M R Philips; J P Buyon; R Winchester; G Weissmann; S B Abramson
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

10.  Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes.

Authors:  M D Moore; N R Cooper; B F Tack; G R Nemerow
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.